Christin Melton, ELS | Authors


High Microvascular Density in Breast Cancer May be Associated With Bevacizumab Efficacy

November 10, 2015

Findings from a recent study suggest that women whose breast cancers have a higher proportion of blood vessels may benefit more from neoadjuvant treatment with bevacizumab than women whose tumors have a lower density of blood vessels.

Thinking Out of the Target May Offer Clues to the Origin of Cancer

February 04, 2015

During the past year, many corporations, academic institutions, and government health organizations announced new funding or collaborative efforts totaling billions of dollars to identify genetic targets for novel cancer therapies.